Cited by 144Transplantation: Methods and OutcomesOrgan and Tissue Transplantation ResearchXenotransplantation and immune response

Alloantibody and complement promote T cell–mediated cardiac allograft vasculopathy through noncanonical nuclear factor-κB signaling in endothelial cells

Open access
Jane-wit, Dan, Manes, Thomas D., Yi, Tai, Qin, Lingfeng, Clark, Pamela, Kirkiles-Smith, Nancy C., Abrahimi, Parwiz, Devalliere, Julie +4 more·2013·Circulation

Abstract

Background—: Cardiac allograft vasculopathy is the major cause of late allograft loss after heart transplantation. Cardiac allograft vasculopathy lesions contain alloreactive T cells that secrete interferon-γ, a vasculopathic cytokine, and occur more frequently in patients with donor-specific antibody. Pathological interactions between these immune effectors, representing cellular and humoral immunity, respectively, remain largely unexplored. Methods and Results—: We used human panel reactive antibody to form membrane attack complexes on allogeneic endothelial cells in vitro and in vivo. Rather than inducing cytolysis, membrane attack complexes upregulated inflammatory genes, enhancing the capacity of endothelial cells to recruit and activate allogeneic interferon-γ––producing CD4 + T cells in a manner dependent on the activation of noncanonical nuclear factor-κB signaling. Noncanonical nuclear factor-κB signaling was detected in situ within endothelial cells both in renal biopsies from transplantation patients with chronic antibody-mediated rejection and in panel-reactive antibody––treated human coronary artery xenografts in immunodeficient mice. On retransplantation into immunodeficient hosts engrafted with human T cells, panel-reactive antibody––treated grafts recruited more interferon-γ––producing T cells and enhanced cardiac allograft vasculopathy lesion formation. Conclusions—: Alloantibody and complement deposition on graft endothelial cells activates noncanonical nuclear factor-κB signaling, initiating a proinflammatory gene program that enhances alloreactive T cell activation and development of cardiac allograft vasculopathy. Noncanonical nuclear factor-κB signaling in endothelial cells, observed in human allograft specimens and implicated in lesion pathogenesis, may represent a target for new pharmacotherapies to halt the progression of cardiac allograft vasculopathy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.113.002972

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Rahmani M, Cruz RP, Granville DJ, McManus BM. Allograft vasculopa- thy versus atherosclerosis. Circ Res. 2006;99:801-815.
  2. Ihrcke NS, Platt JL. Shedding of heparan sulfate proteoglycan by stimu- lated endothelial cells: evidence for proteolysis of cell-surface molecules. J Cell Physiol. 1996;168:625-637.

Cited by

Sorted by citations

Authors
Jane-wit, D., Manes, T. D., Yi, T., Qin, L., Clark, P., Kirkiles-Smith, N. C., Abrahimi, P., Devalliere, J., Moeckel, G., Kulkarni, S., Tellides, G., & Pober, J. S.
Affiliations
  • From the Section of Cardiovascular Medicine, Department of Internal Medicine (D.J.-w.), Department of Immunobiology (T.D.M., N.C.K.-S., P.A., J.D., J.S.P.), Department of Surgery (T.Y., L.W., S.K., G.T.), Department of Neurology (P.C.), and Department of Pathology (G.M., J.S.P.), Yale School of Medicine, New Haven, CT.
  • Yale University (US)
Venue
Circulation
Published
2013-12
Volume
128
Issue
23
Pages
2504-2516
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2132809216
Cited by
144
References
36
Citations by year
2026: 9 · 2025: 12 · 2024: 6 · 2023: 11 · 2022: 8 · 2021: 14 · 2020: 11 · 2019: 17 · 2018: 10 · 2017: 14 · 2016: 10 · 2015: 14 · 2014: 8
FWCI
10.51
Type
journal article
Language
en
Open access
Locations
  • Circulation (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute (HL109455, R01HL109455, R01HL051014, T32HL007974)
  • National Institute of General Medical Sciences (T32GM007205)
  • National Institute of Allergy and Infectious Diseases (T32AI089704)
Topics
  • Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
  • Health Sciences › Medicine › Transplantation › Organ and Tissue Transplantation Research
  • Health Sciences › Medicine › Surgery › Xenotransplantation and immune response
Keywords
cardiac allograft vasculopathy, alloantibodies, complement system, non-canonical NF-κB signaling, endothelial cells, interferon-gamma, CD4+ T cells, donor-specific antibodies, antibody-mediated rejection, heart transplantation, membrane attack complex, chronic rejection
MeSH terms
Animals, Cells, Cultured, Complement System Proteins, Coronary Vessels, Female, Humans, Isoantibodies, Signal Transduction, T-Lymphocyte Subsets, NF-kappa B, Mice, SCID, Endothelial Cells, Mice, Human Umbilical Vein Endothelial Cells, Allografts, Heterografts

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review